These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study. Svenningsson P; Rosenblad C; Af Edholm Arvidsson K; Wictorin K; Keywood C; Shankar B; Lowe DA; Björklund A; Widner H Brain; 2015 Apr; 138(Pt 4):963-73. PubMed ID: 25669730 [TBL] [Abstract][Full Text] [Related]
14. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029 [TBL] [Abstract][Full Text] [Related]
15. Levodopa and the progression of Parkinson's disease. Fahn S; Oakes D; Shoulson I; Kieburtz K; Rudolph A; Lang A; Olanow CW; Tanner C; Marek K; N Engl J Med; 2004 Dec; 351(24):2498-508. PubMed ID: 15590952 [TBL] [Abstract][Full Text] [Related]
16. Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias. Tarsy D; Parkes JD; Marsden CD J Neurol Neurosurg Psychiatry; 1975 Apr; 38(4):331-5. PubMed ID: 1095689 [TBL] [Abstract][Full Text] [Related]
17. [Randomized study during a year of early combination of L-dopa/lisuride in Parkinson disease]. Vermersch P; Fondarai J; Petit H Therapie; 1991; 46(6):481-6. PubMed ID: 1819154 [TBL] [Abstract][Full Text] [Related]